Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Englert

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 23, 2004
Templated ceramic microstructures by using the breath-figure methodBrian C Englert, Stefan Scholz, Peter J Leech, et al.
Sportverletzung Sportschaden : Organ Der Gesellschaft Fur Orthopadisch-Traumatologische Sportmedizin|January 29, 2010
[Sports and activities after achilles tendon injury of the recreational athlete]B Kinner, M Seemann, C Roll, et al.
Journal of Medicinal Chemistry|April 12, 2001
Cardioselective K(ATP) channel blockers derived from a new series of m-anisamidoethylbenzenesulfonylthioureasH C Englert, U Gerlach, H Goegelein, et al.
The Journal of Biological Chemistry|October 26, 2000
The Wilms' tumor gene product (WT1) modulates the response to 1,25-dihydroxyvitamin D3 by induction of the vitamin D receptorU Maurer, F Jehan, C Englert, et al.
Oncogene|May 8, 1998
E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cellsS Maheswaran, C Englert, S B Lee, et al.
Cardiovascular Drugs and Therapy|April 27, 2004
Selective block of sarcolemmal IKATP in human cardiomyocytes using HMR 1098Stefan Kääb, Ludwig Zwermann, Andreas Barth, et al.
The American Journal of Physiology|May 1, 1991
Macromolecular conjugates of transport inhibitors: new tools for probing topography of anion transport proteinsO Eidelman, P Yani, H C Englert, et al.
International Journal of Pharmaceutics|March 30, 2006
Lipidic implants for controlled release of bioactive insulin: effects on cartilage engineered in vitroB Appel, A Maschke, B Weiser, et al.
Arzneimittel-Forschung|October 1, 1992
Cardiovascular effects of the novel potassium channel opener (3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxo- 1-pyrrolidinyl)-6-phenylsulfonylchromane hemihydrateW Linz, E Klaus, U Albus, et al.
Pflugers Archiv : European Journal of Physiology|July 1, 1991
Different types of blockers of the intermediate-conductance outwardly rectifying chloride channel in epitheliaM Tilmann, K Kunzelmann, U Fröbe, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 23, 2004
Templated ceramic microstructures by using the breath-figure methodBrian C Englert, Stefan Scholz, Peter J Leech, et al.
Sportverletzung Sportschaden : Organ Der Gesellschaft Fur Orthopadisch-Traumatologische Sportmedizin|January 29, 2010
[Sports and activities after achilles tendon injury of the recreational athlete]B Kinner, M Seemann, C Roll, et al.
Journal of Medicinal Chemistry|April 12, 2001
Cardioselective K(ATP) channel blockers derived from a new series of m-anisamidoethylbenzenesulfonylthioureasH C Englert, U Gerlach, H Goegelein, et al.
The Journal of Biological Chemistry|October 26, 2000
The Wilms' tumor gene product (WT1) modulates the response to 1,25-dihydroxyvitamin D3 by induction of the vitamin D receptorU Maurer, F Jehan, C Englert, et al.
Oncogene|May 8, 1998
E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cellsS Maheswaran, C Englert, S B Lee, et al.
Cardiovascular Drugs and Therapy|April 27, 2004
Selective block of sarcolemmal IKATP in human cardiomyocytes using HMR 1098Stefan Kääb, Ludwig Zwermann, Andreas Barth, et al.
The American Journal of Physiology|May 1, 1991
Macromolecular conjugates of transport inhibitors: new tools for probing topography of anion transport proteinsO Eidelman, P Yani, H C Englert, et al.
International Journal of Pharmaceutics|March 30, 2006
Lipidic implants for controlled release of bioactive insulin: effects on cartilage engineered in vitroB Appel, A Maschke, B Weiser, et al.
Arzneimittel-Forschung|October 1, 1992
Cardiovascular effects of the novel potassium channel opener (3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxo- 1-pyrrolidinyl)-6-phenylsulfonylchromane hemihydrateW Linz, E Klaus, U Albus, et al.
Pflugers Archiv : European Journal of Physiology|July 1, 1991
Different types of blockers of the intermediate-conductance outwardly rectifying chloride channel in epitheliaM Tilmann, K Kunzelmann, U Fröbe, et al.
Pageof 9